-
Racial/Ethnic Disparities in Pneumococcal Vaccination Rates Among the Elderly: Trends and Associated Factors in the U.S., 2018-2023
Mar 10, 2025, 14:00 PM -
Cost Per Responder Analysis of Patients With 3 Previous Lines and Lenalidomide Refractory Multiple Myeloma Who Received Cilta-Cel in the Brazilian Private Health System
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization Disruptions During the COVID-19 Era and Methodological Considerations: A Review
Mar 10, 2025, 14:00 PM -
What Proportion of the Total Value Generated by New Drugs Accrues to Manufacturers? A Review of Empirical Estimates of Producer Surplus
Mar 10, 2025, 14:00 PM -
Use of the Glucocorticoid Toxicity Index-Metabolic Domains Instrument to Quantify Glucocorticoid Toxicity in Adults With Chronic Inflammatory Demyelinating Polyneuropathy Using Electronic Health Records in the United States
Mar 10, 2025, 14:00 PM -
The Cost-Effectiveness of Eteplirsen vs. Standard of Care in Delaying the Progression of Duchenne Muscular Dystrophy
Mar 10, 2025, 14:00 PM -
Development of Hungarian One-Day Surgical Care in the Public-Funded National Healthcare System From 2010 to 2023
Mar 10, 2025, 14:00 PM -
The Social Distribution of Quality Adjusted Life Expectancy (QALE) Among Deprivation Subgroups in China
Mar 10, 2025, 14:00 PM -
Understanding Predictors of Early-Onset Colorectal Cancer in Personal Health Data with Machine Learning
Mar 10, 2025, 14:00 PM -
Characteristics and Adherence of Patients Initiating Injectable Cabotegravir for HIV Treatment or Prevention
Mar 10, 2025, 14:00 PM -
Prevalence of Claims-Reported Pruritus in Patients With Primary Biliary Cholangitis Overall and Among Those Treated With Obeticholic Acid
Mar 10, 2025, 14:00 PM -
Measuring Patient Engagement: The Importance of a Framework
Mar 10, 2025, 14:00 PM -
Insight into Approvals, Marketing, and Pricing of New Medicines 2018 to 2022
Mar 10, 2025, 14:00 PM -
Survival Analysis in Breast Cancer Patients Treated with Targeted Therapies and Conventional Therapies in the US: A Comparative Real World Study
Mar 10, 2025, 14:00 PM -
Superior Performance of Generative AI After Application of Mixture-of-Agents LLMs in Outcomes Research
Mar 10, 2025, 14:00 PM -
The Economic Burden of Narcolepsy in the United States: Matched Analysis of National Health and Wellness Survey Data
Mar 10, 2025, 14:00 PM -
Examining Burden of Disease and Access to Care in Adults with X-Linked Hypophosphatemia in Brazil
Mar 10, 2025, 14:00 PM -
Formulary Inclusion for Oncologic Indications: Comparing FDA-Approved Indications and Off-Label Compendia Support
Mar 10, 2025, 14:00 PM -
Economic Burden and Healthcare Resource Utilization (HCRU) Associated with High-Risk Papillary Stage Ta & T1 (PAPTa1) Non-Muscle Invasive Bladder Cancer (NMIBC) Patients, 2008-2019
Mar 10, 2025, 14:00 PM -
Navigating Scarcity: Leveraging AI to Address the Challenges of Identifying Rare Disease Key Opinion Leaders
Mar 10, 2025, 14:00 PM
